舌下含服粉尘螨滴剂联合氯雷他定治疗儿童过敏性哮喘伴 变应性鼻炎的疗效及机制
作者: |
1闫晶晶
1 陆军军医大学第二附属医院耳鼻咽喉科,重庆 400037 |
通讯: |
闫晶晶
Email: yanjingjinglj@163.com |
DOI: | 10.3978/j.issn.2095-6959.2019.07.009 |
摘要
目的:观察儿童过敏性哮喘伴变应性鼻炎应用舌下免疫疗法(sublingual immunotherapy,SLIT)联合氯雷他定治疗效果及其作用机制。方法:选取80例过敏性哮喘伴变应性鼻炎患儿,按照随机数字法则分为联合治疗组和标准治疗组,其中标准治疗组给予氯雷他定进行治疗,联合治疗组患儿给予舌下含服粉尘螨滴剂联合氯雷他定治疗,治疗前和治疗后3个月,对患儿的哮喘和鼻炎严重程度、肺通气功能进行评价,对比两组患儿的免疫因子、T淋巴细胞亚群和炎症指标。结果:治疗前,两组患儿哮喘症状评分、鼻炎症状评分、肺通气功能、免疫因子、T淋巴细胞亚群和炎症指标差异无统计学意义(P>0.05);治疗后两组哮喘症状评分和鼻炎症状评分均明显低于治疗前(P<0.05),且联合治疗组与标准治疗组相比更低,差异具有统计学意义(P<0.05);两组FEV1,FVC和PEF均明显高于治疗前(P<0.05),且联合治疗组明显高于标准治疗组,差异具有统计学意义(P<0.05);两组IFN-γ水平均明显升高,IL-4和IL-17水平均明显下降(P<0.05),联合治疗组变化最为显著,与标准治疗组相比,差异具有统计学意义(P<0.05);两组IgE水平均明显下降,IgG4水平均明显升高(P<0.05),联合治疗组变化最为显著,与标准治疗组相比,差异具有统计学意义(P<0.05);两组患儿的CD3+,CD4+及CD4+/CD8+水平均明显升高,CD8+水平均明显下降(P<0.05),联合治疗组变化最为显著,和标准治疗组相比,差异具有统计学意义(P<0.05)。结论:舌下含服粉尘螨滴剂联合氯雷他定治疗小儿变应性鼻炎合并哮喘效果显著,提高免疫功能、降低炎症反应和促进肺功能改善可能是其作用机制。
关键词:
哮喘;变应性鼻炎;炎性指标;免疫功能;粉尘螨滴剂
Clinical effect and its mechanism of sublingual administration of dust mite drops combined with loratadine in the treatment of children with allergic asthma complicated with allergic rhinitis
CorrespondingAuthor: YAN Jingjing Email: yanjingjinglj@163.com
DOI: 10.3978/j.issn.2095-6959.2019.07.009
Abstract
Objective: To observe the efficacy and mechanism of the treatment of children with allergic asthma complicated with allergic rhinitis with sublingual immunotherapy combined with loratadine. Methods: Eighty cases of children with allergic asthma complicated with allergic rhinitis were selected and divided into a combined treatment group and a standard treatment group according to the method of random numbers. The standard treatment group was treated with loratadine, and the combined treatment group was treated with sublingual administration of dust mite drops combined with loratadine. Before and after the treatment for 3 months, the severity of asthma and rhinitis, pulmonary ventilation function of the patients were evaluated; the immune factors, T lymphocyte subgroup and inflammation index between the two groups were compared. Results: Before the treatment, the asthma symptom scores, rhinitis symptom scores, pulmonary ventilation function, immune factors, T lymphocyte subgroup and inflammation index had no statistical significance (P>0.05); after the treatment, asthma symptom scores and rhinitis symptom scores were significantly lower than those before the treatment (P<0.05), and the scores in the joint treatment group were significantly lower than those in the standard treatment group (P<0.05); FEV1, FVC and PEF were significantly higher than those before the treatment in the two groups (P<0.05), and the levels in the combined treatment group was significantly higher than those in the standard treatment group (P<0.05). IFN-γ level was significantly increased in both groups, and IL-4 and Il-17 levels were significantly decreased (P<0.05), the changes in the combined treatment group were more significant than those in the standard treatment group (P<0.05). IgE level was significantly decreased and IgG4 level were significantly increased in both groups (P<0.05), and the changes were more significant in the combined treatment group when compared with the standard treatment group (P<0.05). CD3+, CD4+ and CD4+/CD8+ levels were significantly increased and CD8+ levels were significantly decreased in the two groups (P<0.05); the changes were more significant in the combined treatment group when compared with the standard treatment group (P<0.05). Conclusion: Sublingual dust mite drops combined with fratadine in the treatment of pediatric allergic rhinitis with asthma has a significant effect.
Keywords:
asthma; allergic rhinitis; inflammatory index; immune function; dust mite drops